Milestone Scientific Inc. Expands Reach with CompuFlo Epidural System Rollout
In a significant move to enhance its presence in the medical technology sector, Milestone Scientific Inc. has initiated a commercial rollout of its CompuFlo Epidural System at Pain Doctors Medical LLC. This strategic expansion underscores the company’s commitment to advancing pain management solutions across various medical fields.
Milestone Scientific Inc., a key player in the health care equipment and supplies industry, specializes in the development and distribution of computer-controlled local anesthetic delivery systems. These systems are widely utilized in plastic surgery, podiatry, dermatology, and orthopedics, reflecting the company’s broad impact on the medical community. With a global operational footprint, Milestone Scientific continues to serve healthcare professionals and patients worldwide.
The company’s recent stock performance has been a topic of interest among investors. Over the past year, Milestone Scientific’s stock has experienced notable fluctuations, reaching a 52-week high of $1.39 USD on January 23, 2025. Conversely, the stock hit a 52-week low of $0.58 USD on July 7, 2024. As of May 13, 2025, the closing price stood at $0.89 USD. These variations highlight the dynamic nature of the market and the challenges faced by companies in the health care sector.
Financial metrics further illustrate the company’s current valuation landscape. With a price-to-earnings ratio of -18.18, Milestone Scientific presents a complex picture for investors. The price-to-book ratio, however, is 14.45 USD, suggesting a different perspective on the company’s market value. Despite these challenges, the company’s market capitalization remains at $84,650,000 USD, indicating a solid foundation in the industry.
Founded in 1995, Milestone Scientific has a long-standing history in the medical technology field. Listed on the NYSE American exchange, the company continues to innovate and expand its product offerings. For those interested in learning more about Milestone Scientific and its contributions to healthcare, additional information is available on their website at www.milestonescientific.com .
As Milestone Scientific moves forward with the commercial rollout of the CompuFlo Epidural System, the company aims to solidify its position as a leader in pain management technology. This initiative not only enhances the company’s product portfolio but also reinforces its commitment to improving patient care through innovative solutions.